Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU, and etoposide (CBV) followed by autologous stem cell transplant

Pneumonitis is a complication of high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT) regimens containing BCNU. Our goal was to define the incidence and risk factors for pneumonitis in lymphoma patients receiving a uniform conditioning regimen in the modern era. We studied 222...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lane, Andrew A., Armand, Philippe, Feng, Yang, Neuberg, Donna S., Abramson, Jeremy S., Brown, Jennifer R., Fisher, David C., LaCasce, Ann S., Jacobsen, Eric D., McAfee, Steven L., Spitzer, Thomas R., Freedman, Arnold S., Chen, Yi-Bin
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3376378/
https://ncbi.nlm.nih.gov/pubmed/22132836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.645208
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires